PDCD1 and non-small cell lung carcinoma: Exosomes containing biomarkers such as PD-1 or PD-L1 predict better response to IT in melanoma and NSCLC, whereas exosomes containing hsa-miR-320b/c/d or hsa-miR-125b-5 predict worse response to IT in NSCLC.